Clinical Trial Update: Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial update examining neurocognitive outcomes with bilateral or unilateral hippocampal-avoidance whole-brain radiotherapy plus memantine for brain meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Malignant Neoplasm to Brain

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Metastatic Malignant Neoplasm to Brain | Phase 2 | Status: UNKNOWN